

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 6.31105510 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.40229652 |
| 3 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.22807530 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.22190286 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.03375635 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.00271278 |
| 7 | detection of other organism (GO:0098543) | 4.99146142 |
| 8 | detection of bacterium (GO:0016045) | 4.95064067 |
| 9 | B cell mediated immunity (GO:0019724) | 4.94675721 |
| 10 | regulation of antigen processing and presentation (GO:0002577) | 4.74099278 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.71540559 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.62910303 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.62910303 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.62910303 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.62910303 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.62910303 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.62910303 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 4.52969828 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.47958477 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.47958477 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.41955505 |
| 22 | response to peptidoglycan (GO:0032494) | 4.39690874 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 4.32520295 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.28206583 |
| 25 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 4.25916090 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 4.22192058 |
| 27 | detection of external biotic stimulus (GO:0098581) | 4.01481240 |
| 28 | positive thymic T cell selection (GO:0045059) | 4.01136453 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.97847574 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85641668 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.84813163 |
| 32 | T-helper 1 type immune response (GO:0042088) | 3.75526284 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68908271 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 3.68789962 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 3.66707778 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.66023509 |
| 37 | positive regulation of mast cell degranulation (GO:0043306) | 3.63243653 |
| 38 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.63243653 |
| 39 | detection of biotic stimulus (GO:0009595) | 3.56595776 |
| 40 | microglial cell activation (GO:0001774) | 3.54368325 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.45730566 |
| 42 | response to host immune response (GO:0052572) | 3.45038019 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.45038019 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.43043433 |
| 45 | positive regulation of type 2 immune response (GO:0002830) | 3.40106770 |
| 46 | cellular extravasation (GO:0045123) | 3.37385750 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.37383986 |
| 48 | cellular response to type I interferon (GO:0071357) | 3.33381894 |
| 49 | type I interferon signaling pathway (GO:0060337) | 3.33381894 |
| 50 | * cellular response to interferon-gamma (GO:0071346) | 3.32693208 |
| 51 | response to type I interferon (GO:0034340) | 3.30874790 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.29922463 |
| 53 | neutrophil activation (GO:0042119) | 3.26767804 |
| 54 | regulation of mast cell activation (GO:0033003) | 3.23642216 |
| 55 | macrophage activation (GO:0042116) | 3.23486542 |
| 56 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.23038589 |
| 57 | defense response to protozoan (GO:0042832) | 3.20617015 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18406026 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.18153760 |
| 60 | detection of molecule of bacterial origin (GO:0032490) | 3.17436177 |
| 61 | granulocyte activation (GO:0036230) | 3.17346423 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.15144512 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 3.12487382 |
| 64 | regulation of leukocyte degranulation (GO:0043300) | 3.11507288 |
| 65 | respiratory burst (GO:0045730) | 3.09953439 |
| 66 | response to host (GO:0075136) | 3.09864682 |
| 67 | response to host defenses (GO:0052200) | 3.09864682 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.09864682 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 3.08240976 |
| 70 | * response to interferon-gamma (GO:0034341) | 3.07949776 |
| 71 | regulation of tolerance induction (GO:0002643) | 3.06085724 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 3.02943330 |
| 73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02815837 |
| 74 | response to protozoan (GO:0001562) | 3.01293639 |
| 75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00848937 |
| 76 | response to muramyl dipeptide (GO:0032495) | 2.98293794 |
| 77 | myeloid dendritic cell activation (GO:0001773) | 2.96191564 |
| 78 | positive T cell selection (GO:0043368) | 2.93303411 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 2.92854029 |
| 80 | leukocyte aggregation (GO:0070486) | 2.92696763 |
| 81 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.91509126 |
| 82 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.91452395 |
| 83 | regulation of hypersensitivity (GO:0002883) | 2.89934293 |
| 84 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87232046 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86180922 |
| 86 | positive regulation of leukocyte degranulation (GO:0043302) | 2.84673640 |
| 87 | negative regulation of innate immune response (GO:0045824) | 2.83445654 |
| 88 | * T cell costimulation (GO:0031295) | 2.81110241 |
| 89 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.80566523 |
| 90 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79998695 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.77289978 |
| 92 | * lymphocyte costimulation (GO:0031294) | 2.76687475 |
| 93 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76480296 |
| 94 | positive regulation of macrophage cytokine production (GO:0060907) | 2.74692910 |
| 95 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.73760633 |
| 96 | T cell selection (GO:0045058) | 2.73129019 |
| 97 | germinal center formation (GO:0002467) | 2.72167194 |
| 98 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.70192524 |
| 99 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.69900197 |
| 100 | T cell migration (GO:0072678) | 2.67388994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.32460743 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.42137244 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.62343280 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.57044087 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.36211317 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35478813 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.27979957 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15819658 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83749831 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.82765072 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.74554652 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67601209 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.65082985 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55103360 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.54575245 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.45073511 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42829833 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41816872 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37325512 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35355505 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.31550383 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.26939065 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.17524069 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.16297107 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.16126163 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09536407 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.01827299 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00909695 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.94987424 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94771999 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94730769 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92132764 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86410237 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82681540 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80966621 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.80209866 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77618452 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.75449719 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75381214 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.71849558 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71534278 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.69640620 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67671429 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67297388 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65803138 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57070041 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46674132 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44506944 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42249850 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42215867 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41182512 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39035052 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.37472614 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.35207756 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34724546 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32052261 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30884264 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30419431 |
| 59 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30058279 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29952753 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28961786 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27831681 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25930736 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24317288 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21156297 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20124377 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19521524 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18940946 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18665792 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18271271 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16894160 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14643348 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13679739 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12933902 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12560870 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11742447 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10985727 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10933659 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10337764 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09141769 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09114544 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06896226 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04907581 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04132872 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99368214 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98974087 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98330509 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97629151 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95354499 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94002501 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92656317 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91394068 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 0.89518808 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86129657 |
| 95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83373798 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82633672 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80974420 |
| 98 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80493586 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80416673 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78854757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.57109029 |
| 2 | MP0003724_increased_susceptibility_to | 3.74090662 |
| 3 | MP0003436_decreased_susceptibility_to | 3.53340527 |
| 4 | MP0003303_peritoneal_inflammation | 3.46186089 |
| 5 | MP0005671_abnormal_response_to | 3.27364648 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.09738821 |
| 7 | MP0001790_abnormal_immune_system | 3.09267751 |
| 8 | MP0005387_immune_system_phenotype | 3.09267751 |
| 9 | MP0002419_abnormal_innate_immunity | 2.99503165 |
| 10 | MP0001800_abnormal_humoral_immune | 2.99066794 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.98307044 |
| 12 | MP0000685_abnormal_immune_system | 2.92223389 |
| 13 | MP0009785_altered_susceptibility_to | 2.87271622 |
| 14 | MP0005025_abnormal_response_to | 2.83855543 |
| 15 | MP0006082_CNS_inflammation | 2.82658763 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.74000532 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.66913635 |
| 18 | MP0002723_abnormal_immune_serum | 2.63875803 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.52748724 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.45251331 |
| 21 | MP0001819_abnormal_immune_cell | 2.43685825 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.23664849 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.07083657 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.02288880 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.93576028 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.90545047 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.88909155 |
| 28 | MP0009840_abnormal_foam_cell | 1.85514687 |
| 29 | MP0002405_respiratory_system_inflammati | 1.83776562 |
| 30 | MP0000716_abnormal_immune_system | 1.82136459 |
| 31 | MP0009278_abnormal_bone_marrow | 1.80042159 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.77923734 |
| 33 | MP0009764_decreased_sensitivity_to | 1.77315070 |
| 34 | MP0003075_altered_response_to | 1.75003652 |
| 35 | MP0002398_abnormal_bone_marrow | 1.71953132 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.64703406 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.63396576 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.63091651 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.63091651 |
| 40 | MP0008469_abnormal_protein_level | 1.62090620 |
| 41 | MP0003828_pulmonary_edema | 1.54022779 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.53959626 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.53327011 |
| 44 | MP0001853_heart_inflammation | 1.52438930 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.50859102 |
| 46 | MP0004947_skin_inflammation | 1.50719804 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.48558131 |
| 48 | MP0000604_amyloidosis | 1.46845378 |
| 49 | MP0002429_abnormal_blood_cell | 1.45397776 |
| 50 | MP0000343_altered_response_to | 1.41423042 |
| 51 | MP0005166_decreased_susceptibility_to | 1.38592036 |
| 52 | MP0005310_abnormal_salivary_gland | 1.37958079 |
| 53 | MP0002722_abnormal_immune_system | 1.36468695 |
| 54 | MP0003866_abnormal_defecation | 1.27775014 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.25679307 |
| 56 | MP0000858_altered_metastatic_potential | 1.24527040 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.23256552 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.14433325 |
| 59 | MP0005451_abnormal_body_composition | 1.09685247 |
| 60 | MP0003690_abnormal_glial_cell | 1.07270030 |
| 61 | MP0001873_stomach_inflammation | 1.06195248 |
| 62 | MP0002396_abnormal_hematopoietic_system | 1.00530893 |
| 63 | MP0003448_altered_tumor_morphology | 1.00394119 |
| 64 | MP0008260_abnormal_autophagy | 0.98957406 |
| 65 | MP0002132_abnormal_respiratory_system | 0.98133066 |
| 66 | MP0001663_abnormal_digestive_system | 0.95246482 |
| 67 | MP0001851_eye_inflammation | 0.95027533 |
| 68 | MP0009763_increased_sensitivity_to | 0.92814846 |
| 69 | MP0004510_myositis | 0.88410099 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.88112952 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 0.86883110 |
| 72 | MP0008004_abnormal_stomach_pH | 0.86447862 |
| 73 | MP0002006_tumorigenesis | 0.84869249 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.84354216 |
| 75 | MP0000015_abnormal_ear_pigmentation | 0.84163191 |
| 76 | MP0004883_abnormal_blood_vessel | 0.82452766 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.82401399 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.81025621 |
| 79 | MP0005164_abnormal_response_to | 0.79496122 |
| 80 | MP0005390_skeleton_phenotype | 0.79013544 |
| 81 | MP0000249_abnormal_blood_vessel | 0.77258978 |
| 82 | MP0002933_joint_inflammation | 0.72089650 |
| 83 | MP0000920_abnormal_myelination | 0.71268401 |
| 84 | MP0000490_abnormal_crypts_of | 0.70994320 |
| 85 | MP0005165_increased_susceptibility_to | 0.70900105 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.70443342 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.68965191 |
| 88 | MP0003795_abnormal_bone_structure | 0.61843757 |
| 89 | MP0005365_abnormal_bile_salt | 0.61720267 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.57136686 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55910831 |
| 92 | MP0008874_decreased_physiological_sensi | 0.54465704 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.52761772 |
| 94 | MP0005381_digestive/alimentary_phenotyp | 0.52537479 |
| 95 | MP0000609_abnormal_liver_physiology | 0.52375478 |
| 96 | MP0003329_amyloid_beta_deposits | 0.50964235 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.50697992 |
| 98 | MP0004381_abnormal_hair_follicle | 0.49263692 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.48511520 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.46437456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.26798907 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.16574729 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.02851304 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.98840536 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.98840536 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.98840536 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.77625428 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.43887192 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.25961808 |
| 10 | Meningitis (HP:0001287) | 4.09858853 |
| 11 | Agammaglobulinemia (HP:0004432) | 4.08128778 |
| 12 | Myositis (HP:0100614) | 4.07802948 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.05114991 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.95950223 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.94933746 |
| 16 | Obstructive lung disease (HP:0006536) | 3.94933746 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.94383965 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.73197722 |
| 19 | Orchitis (HP:0100796) | 3.69100319 |
| 20 | Recurrent skin infections (HP:0001581) | 3.66669229 |
| 21 | Stomatitis (HP:0010280) | 3.49283314 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.49173623 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.49173623 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.48090417 |
| 25 | Optic neuritis (HP:0100653) | 3.48090417 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.46588782 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.31369063 |
| 28 | Vasculitis (HP:0002633) | 3.30742961 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.29284758 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29218510 |
| 31 | Cellulitis (HP:0100658) | 3.24944281 |
| 32 | Recurrent viral infections (HP:0004429) | 3.24831846 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.18596758 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 3.16899878 |
| 35 | Urticaria (HP:0001025) | 3.10244468 |
| 36 | Abnormality of the prostate (HP:0008775) | 3.06866683 |
| 37 | Loss of speech (HP:0002371) | 3.05667346 |
| 38 | Encephalitis (HP:0002383) | 2.99161096 |
| 39 | Increased IgE level (HP:0003212) | 2.91516615 |
| 40 | Hemoptysis (HP:0002105) | 2.90822152 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.84586598 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.84107101 |
| 43 | Colitis (HP:0002583) | 2.81036600 |
| 44 | Chest pain (HP:0100749) | 2.79094470 |
| 45 | Gingivitis (HP:0000230) | 2.73343308 |
| 46 | Disinhibition (HP:0000734) | 2.66067567 |
| 47 | Purpura (HP:0000979) | 2.65296504 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.63696084 |
| 49 | Osteomyelitis (HP:0002754) | 2.63055238 |
| 50 | Pustule (HP:0200039) | 2.62226272 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.61792813 |
| 52 | Gastrointestinal stroma tumor (HP:0100723) | 2.60396783 |
| 53 | Glomerulonephritis (HP:0000099) | 2.57464856 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.50940710 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.50834072 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.48371016 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.48371016 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.48371016 |
| 59 | Restrictive lung disease (HP:0002091) | 2.47190463 |
| 60 | Petechiae (HP:0000967) | 2.46373634 |
| 61 | Amyloidosis (HP:0011034) | 2.44982991 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.42130021 |
| 63 | Recurrent pneumonia (HP:0006532) | 2.35223249 |
| 64 | Epistaxis (HP:0000421) | 2.35205782 |
| 65 | Increased serum ferritin (HP:0003281) | 2.34458501 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.34040780 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.33337794 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33337794 |
| 69 | Pulmonary embolism (HP:0002204) | 2.31291031 |
| 70 | Chronic otitis media (HP:0000389) | 2.31003397 |
| 71 | Increased IgM level (HP:0003496) | 2.29925448 |
| 72 | T lymphocytopenia (HP:0005403) | 2.29870078 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.28993011 |
| 74 | Recurrent sinusitis (HP:0011108) | 2.28588415 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.26640031 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.26207407 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.25972363 |
| 78 | Premature loss of primary teeth (HP:0006323) | 2.25082469 |
| 79 | Abnormality of T cell number (HP:0011839) | 2.25024332 |
| 80 | Skin rash (HP:0000988) | 2.24802894 |
| 81 | Sepsis (HP:0100806) | 2.24633442 |
| 82 | Leukocytosis (HP:0001974) | 2.24221936 |
| 83 | Abnormality of T cells (HP:0002843) | 2.20604196 |
| 84 | Prostate neoplasm (HP:0100787) | 2.20575669 |
| 85 | Granulocytopenia (HP:0001913) | 2.19428981 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.18732937 |
| 87 | Arterial thrombosis (HP:0004420) | 2.16914129 |
| 88 | Gangrene (HP:0100758) | 2.15030452 |
| 89 | Hypertensive crisis (HP:0100735) | 2.14149675 |
| 90 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12250948 |
| 91 | Abnormality of B cell number (HP:0010975) | 2.11449038 |
| 92 | Lymphopenia (HP:0001888) | 2.11224915 |
| 93 | Polyneuropathy (HP:0001271) | 2.11027966 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 2.08903947 |
| 95 | Mutism (HP:0002300) | 2.08579813 |
| 96 | IgM deficiency (HP:0002850) | 2.08381664 |
| 97 | Complement deficiency (HP:0004431) | 2.07994943 |
| 98 | Pulmonary fibrosis (HP:0002206) | 2.07324925 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 2.06859119 |
| 100 | Thrombocytosis (HP:0001894) | 2.03734216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.26483769 |
| 2 | BLK | 4.03947628 |
| 3 | MAP4K1 | 4.02336875 |
| 4 | ERN1 | 3.67569679 |
| 5 | TYK2 | 2.95525640 |
| 6 | KIT | 2.65848327 |
| 7 | FES | 2.44432148 |
| 8 | MAP3K14 | 2.40153908 |
| 9 | TBK1 | 2.34981228 |
| 10 | CSF1R | 2.29745345 |
| 11 | SYK | 2.24161630 |
| 12 | IRAK4 | 2.19410648 |
| 13 | JAK3 | 2.01145403 |
| 14 | IKBKE | 2.00075613 |
| 15 | BTK | 1.99771221 |
| 16 | CSK | 1.99174744 |
| 17 | NME2 | 1.98795557 |
| 18 | TXK | 1.93133069 |
| 19 | TNK2 | 1.87916272 |
| 20 | ZAP70 | 1.83959916 |
| 21 | MAP2K3 | 1.82039635 |
| 22 | TAOK3 | 1.79481411 |
| 23 | MAP3K13 | 1.77781976 |
| 24 | LYN | 1.73536164 |
| 25 | IKBKB | 1.69794443 |
| 26 | MAP3K11 | 1.69054150 |
| 27 | BMPR2 | 1.64262343 |
| 28 | MAP3K3 | 1.54650249 |
| 29 | SIK3 | 1.53023132 |
| 30 | PRPF4B | 1.46997477 |
| 31 | HCK | 1.46524990 |
| 32 | TEC | 1.44921795 |
| 33 | TESK2 | 1.42986643 |
| 34 | FGR | 1.39562323 |
| 35 | GRK6 | 1.38331207 |
| 36 | MATK | 1.35836214 |
| 37 | ITK | 1.34492840 |
| 38 | JAK1 | 1.33463921 |
| 39 | LCK | 1.27447715 |
| 40 | IRAK3 | 1.17104593 |
| 41 | JAK2 | 1.09066013 |
| 42 | TGFBR2 | 1.08692061 |
| 43 | GRK7 | 1.04764694 |
| 44 | BCKDK | 0.95411217 |
| 45 | MAP3K1 | 0.94812418 |
| 46 | KDR | 0.93234247 |
| 47 | CDK19 | 0.85477535 |
| 48 | MARK3 | 0.82190136 |
| 49 | CDC42BPA | 0.79442864 |
| 50 | TAOK2 | 0.74486984 |
| 51 | TAOK1 | 0.71405150 |
| 52 | PDK1 | 0.70389000 |
| 53 | PRKCQ | 0.69472088 |
| 54 | MAPK7 | 0.61569565 |
| 55 | PDPK1 | 0.61343748 |
| 56 | FYN | 0.59281445 |
| 57 | ABL1 | 0.58990559 |
| 58 | MAPK12 | 0.58561370 |
| 59 | CHUK | 0.58042803 |
| 60 | ABL2 | 0.57336901 |
| 61 | STK10 | 0.55012250 |
| 62 | LRRK2 | 0.54192783 |
| 63 | SIK2 | 0.51737123 |
| 64 | PIM2 | 0.49742368 |
| 65 | PIK3CG | 0.49051490 |
| 66 | IRAK1 | 0.47313692 |
| 67 | RIPK1 | 0.47043915 |
| 68 | HIPK2 | 0.45548619 |
| 69 | EPHB1 | 0.43879774 |
| 70 | PIM1 | 0.43403210 |
| 71 | RPS6KL1 | 0.42506446 |
| 72 | RPS6KC1 | 0.42506446 |
| 73 | MAPKAPK2 | 0.41695674 |
| 74 | MAP3K5 | 0.40302205 |
| 75 | MAP2K6 | 0.39914670 |
| 76 | CDK6 | 0.39884285 |
| 77 | MAPK4 | 0.39596790 |
| 78 | MAP2K2 | 0.38994680 |
| 79 | PRKD2 | 0.38228688 |
| 80 | PRKCD | 0.37349215 |
| 81 | ADRBK2 | 0.36960993 |
| 82 | MAPK11 | 0.36616587 |
| 83 | RPS6KA6 | 0.36480027 |
| 84 | IRAK2 | 0.36340388 |
| 85 | TLK1 | 0.36072368 |
| 86 | CDK4 | 0.34252377 |
| 87 | SMG1 | 0.34073869 |
| 88 | MARK2 | 0.32694300 |
| 89 | CAMKK2 | 0.30631831 |
| 90 | FGFR3 | 0.28487719 |
| 91 | PRKD1 | 0.25542660 |
| 92 | DAPK2 | 0.25361397 |
| 93 | DDR2 | 0.25267800 |
| 94 | IGF1R | 0.24749867 |
| 95 | MAPK3 | 0.24524525 |
| 96 | PDK2 | 0.22947664 |
| 97 | TESK1 | 0.22239809 |
| 98 | EGFR | 0.22235095 |
| 99 | MOS | 0.22090563 |
| 100 | ACVR1B | 0.21691436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Asthma_Homo sapiens_hsa05310 | 4.32305490 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 4.24836991 |
| 3 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 3.99833432 |
| 4 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.93721466 |
| 5 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.93133418 |
| 6 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.48761097 |
| 7 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.27952997 |
| 8 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.20234608 |
| 9 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.81946589 |
| 10 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.64778319 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.46582970 |
| 12 | * Viral myocarditis_Homo sapiens_hsa05416 | 2.36527492 |
| 13 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.30167974 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.25107685 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19539440 |
| 16 | * Tuberculosis_Homo sapiens_hsa05152 | 2.13591283 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80761705 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.72941729 |
| 19 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68198188 |
| 20 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.66410654 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64373059 |
| 22 | * Phagosome_Homo sapiens_hsa04145 | 1.62992265 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59999253 |
| 24 | * Influenza A_Homo sapiens_hsa05164 | 1.51095010 |
| 25 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.47164697 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.37057946 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35906618 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31221231 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.20285473 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.18532268 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17903617 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.12874395 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10421325 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04806192 |
| 35 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04258453 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.01430490 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99442328 |
| 38 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.90761285 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89762398 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88065243 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84789704 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82985928 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 0.82668075 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81768990 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80395226 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78228007 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77511114 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75885029 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72938668 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70248368 |
| 51 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69835393 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.66054000 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.65874632 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.61270685 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.60364517 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.56828076 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56250799 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56208452 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48478797 |
| 60 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.47691087 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47079365 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45245597 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38429443 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35558936 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33613804 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33312463 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31633633 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29696906 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.26608844 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.25488203 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25383261 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23583665 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23223161 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22109737 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21616640 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21005134 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20743259 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20090185 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17968373 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17641549 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16933156 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16817059 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.16502865 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16374736 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14976356 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13779950 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13087661 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12780413 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.12706611 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11106627 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08247132 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.07459373 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06633633 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.06316381 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06294345 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.03084568 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.02690620 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.02486403 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.01692552 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.00212256 |

